Implants

Hemostemix Announces New Publication: How NCP-01 Supports Brain Computer Interfaces

Calgary, Alberta--(Newsfile Corp. - September 12, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce…

1 year ago

Forma Medical Launches OptimalHT the World’s First Minimally Invasive Instrumented Hammertoe Arthrodesis Procedure After 50+ Procedures

CAMP HILL, Pa.--(BUSINESS WIRE)--Forma Medical, an emerging innovator in medical device technologies, announces today the launch of OptimalHT, the world’s…

1 year ago

Occlutech Q2 2023 – Continued strong revenue growth

SCHAFFHAUSEN, CH / ACCESSWIRE / September 05, 2023 / Occlutech Holding AG Occlutech Holding AG (Occlutech) is a leading specialist…

1 year ago

Femasys Inc. Obtains Medical Device Establishment License from Health Canada

ATLANTA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs…

1 year ago

Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

Topline Results Expected 1H 2024WATERTOWN, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the…

1 year ago

Mithra prices private placement to raise EUR 20 million in equity

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA…

1 year ago

Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing

PONTE VEDRA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a…

1 year ago

Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring

The Avertix Guardian™ System, the first and only FDA approved implantable heart attack warning system, now available at the Heart…

1 year ago

AcuityMD Signs Miach Orthopedics, Now Over 100 Medical Device Customers

AcuityMD’s data-driven commercial platform has helped device innovators identify more than 60,000 untapped healthcare professionals and over $6 billion in…

1 year ago

Femasys Inc. Announces Financial Results for the Second Quarter Ended June 30, 2023 and Provides Corporate Update

                  - Patient enrollment has commenced in landmark pivotal trial for lead product…

1 year ago